[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PL294368A1 - Method of obtaining adenosine 2', 3'-carbonates - Google Patents

Method of obtaining adenosine 2', 3'-carbonates

Info

Publication number
PL294368A1
PL294368A1 PL29436891A PL29436891A PL294368A1 PL 294368 A1 PL294368 A1 PL 294368A1 PL 29436891 A PL29436891 A PL 29436891A PL 29436891 A PL29436891 A PL 29436891A PL 294368 A1 PL294368 A1 PL 294368A1
Authority
PL
Poland
Prior art keywords
carbonates
adenosine
obtaining
obtaining adenosine
Prior art date
Application number
PL29436891A
Other languages
English (en)
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of PL294368A1 publication Critical patent/PL294368A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
PL29436891A 1990-08-16 1991-08-13 Method of obtaining adenosine 2', 3'-carbonates PL294368A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4025879A DE4025879A1 (de) 1990-08-16 1990-08-16 Neue adenosin derivate, deren herstellung und verwendung

Publications (1)

Publication Number Publication Date
PL294368A1 true PL294368A1 (en) 1993-06-28

Family

ID=6412310

Family Applications (1)

Application Number Title Priority Date Filing Date
PL29436891A PL294368A1 (en) 1990-08-16 1991-08-13 Method of obtaining adenosine 2', 3'-carbonates

Country Status (11)

Country Link
EP (1) EP0496852A1 (xx)
JP (1) JPH05502889A (xx)
AU (1) AU638600B2 (xx)
CA (1) CA2064869A1 (xx)
CS (1) CS97892A3 (xx)
DE (1) DE4025879A1 (xx)
FI (1) FI921691A0 (xx)
HU (1) HUT60504A (xx)
PL (1) PL294368A1 (xx)
TW (1) TW197448B (xx)
WO (1) WO1992003463A1 (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5165793A (en) * 1992-10-01 1994-04-26 Mcneilab, Inc. Derivatives of 7,8-disubstituted guanosines
GB9301000D0 (en) * 1993-01-20 1993-03-10 Glaxo Group Ltd Chemical compounds
CN114437159B (zh) * 2022-04-11 2022-06-28 佛山市晨康生物科技有限公司 一种环状碳酸酯核苷类化合物及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4167565A (en) * 1976-11-08 1979-09-11 Abbott Laboratories Adenosine-5'-carboxamides and method of use
US4514405A (en) * 1981-09-17 1985-04-30 Merck Patent Gesellschaft Mit Beschrankter Haftung Use of adenosine derivatives as anticonvulsants
DE3406533A1 (de) * 1984-02-23 1985-08-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verwendung von adenosin-derivaten als antiallergica und arzneimittel, die diese enthalten
AU579412B2 (en) * 1984-10-26 1988-11-24 Warner-Lambert Company N` - substituted adenosines

Also Published As

Publication number Publication date
HUT60504A (en) 1992-09-28
CA2064869A1 (en) 1992-02-17
TW197448B (xx) 1993-01-01
HU9201080D0 (en) 1992-06-29
CS97892A3 (en) 1992-08-12
JPH05502889A (ja) 1993-05-20
DE4025879A1 (de) 1992-02-20
WO1992003463A1 (de) 1992-03-05
AU638600B2 (en) 1993-07-01
FI921691A0 (fi) 1992-04-15
EP0496852A1 (de) 1992-08-05
AU8303291A (en) 1992-03-17

Similar Documents

Publication Publication Date Title
PL295811A2 (en) Method of obtaining 1,2-dihydro-2-ketopyridines
PL295148A1 (en) Method of obtaining novel derivatives of (3 r,4 s)-azetydynone-2
PL271722A1 (en) Method of obtaining novel 2',3'-didesoxynucleosides
PL290856A1 (en) Method of obtaining Ÿ-lactames
PL299081A1 (en) Method of obtaining biprotected 2,3-di (hexomethyl) cyclobutanol
PL294368A1 (en) Method of obtaining adenosine 2', 3'-carbonates
PL292813A1 (en) Method of obtaining novel derivatives of 15-nitro-2Ÿ, 3Ÿ, 6,7-tetrahydrotabersonine
EP0474016A3 (en) Method for the preparation of 2,3-dihydro-benzofuranes
PL288627A1 (en) Method of obtaining pentafluorodichloropropanes
PL297518A1 (en) Method of obtaining 4,6-dialkoxypyrimidines
PL283907A1 (en) Method of obtaining oligoestrols
PL286447A1 (en) Method of obtaining 1,3-dimethyl-4-/-hydroxyaminopropane/-uracil
PL276098A1 (en) Method of obtaining 2,3-dibromide-2-butene-1,4-diole
PL290200A1 (en) Method of obtaining novel pyrol (2,3-b) indoloketones
PL287126A1 (en) Method of obtaining pululane
PL292308A1 (en) Method of obtaining tioxane
PL284237A1 (en) Method of obtaining 1,3-diphenyloxypropanol-2
PL298037A1 (en) Method of obtaining 1,2,3,9-tetrahydro-9-methyl-3-](2-methyl-1h-imidazoil-1)methyl¦-4h-carbazolone-4
CS19290A2 (en) Method of 2,3-diarylquinoxalines preparation
PL290244A1 (en) Method of obtaining novel substituted 1,2,4-triazinediones
PL285570A1 (en) Method of obtaining n-2-minoethyl-3-aminopropyltrimethoxysilane
PL271822A1 (en) Method of obtaining novel n-aminomethyl 1,2-benzoisothiazolynon-3-yl-acetamide
PL280448A1 (en) Method of obtaining 1,2-benzoisothiazolinone-3
PL294887A1 (en) Method of obtaining n 1, n 5, n 10, n 14 - tetrakis/ 2,3-dihydroxy-4-carboxybenzoyl/ tetraazateradecane
PL288367A1 (en) Method of obtaining 1,3-dichloropropanol